# BOISE CASCADE Co: financial statements, quarterly

BCC · NYSE · CIK 1328581 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcc.md) · [Financials](/companies/bcc/financials.md) · [Filings](/companies/bcc/filings.md) · [Insiders](/companies/bcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,834](/filings/0001328581-24-000090.md) | [1,644 d](/filings/0001328581-26-000006.md) | [1,645](/filings/0001328581-25-000058.md) | [1,798](/filings/0001328581-25-000073.md) | [1,714](/filings/0001328581-25-000088.md) | [1,567 d](/filings/0001328581-26-000006.md) | [1,536](/filings/0001328581-26-000016.md) | [1,740](/filings/0001328581-26-000027.md) | [1,668](/filings/0001328581-25-000088.md) | [1,460 d](/filings/0001328581-26-000006.md) | [1,499](/filings/0001328581-26-000016.md) | [1,831](/filings/0001328581-26-000027.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [186](/filings/0001328581-24-000090.md) | [121 d](/filings/0001328581-26-000006.md) | [133](/filings/0001328581-25-000058.md) | [147](/filings/0001328581-25-000073.md) | [117](/filings/0001328581-25-000088.md) | [92.7 d](/filings/0001328581-26-000006.md) | [54.5](/filings/0001328581-26-000016.md) | [80.5](/filings/0001328581-26-000027.md) | [32.3](/filings/0001328581-25-000088.md) | [16.0 d](/filings/0001328581-26-000006.md) | [27.8](/filings/0001328581-26-000016.md) | [84.0](/filings/0001328581-26-000027.md) |
| Interest expense | $m | [6.4](/filings/0001328581-23-000096.md) | [6.4 d](/filings/0001328581-24-000018.md) | [6.1](/filings/0001328581-24-000065.md) | [6.1](/filings/0001328581-25-000073.md) | [6.1](/filings/0001328581-25-000088.md) | [5.8 d](/filings/0001328581-26-000006.md) | [5.3](/filings/0001328581-26-000016.md) | [5.2](/filings/0001328581-26-000027.md) | [5.3](/filings/0001328581-25-000088.md) | [6.0 d](/filings/0001328581-26-000006.md) | [6.0](/filings/0001328581-26-000016.md) | [7.1](/filings/0001328581-26-000027.md) |
| Income tax | $m | [49.0](/filings/0001328581-24-000090.md) | [29.7 d](/filings/0001328581-26-000006.md) | [32.8](/filings/0001328581-25-000058.md) | [38.5](/filings/0001328581-25-000073.md) | [29.8](/filings/0001328581-25-000088.md) | [24.3 d](/filings/0001328581-26-000006.md) | [13.8](/filings/0001328581-26-000016.md) | [18.6](/filings/0001328581-26-000027.md) | [9.1](/filings/0001328581-25-000088.md) | [5.6 d](/filings/0001328581-26-000006.md) | [6.6](/filings/0001328581-26-000016.md) | [21.2](/filings/0001328581-26-000027.md) |
| Net income | $m | [143](/filings/0001328581-24-000090.md) | [97.5 d](/filings/0001328581-26-000006.md) | [104](/filings/0001328581-25-000088.md) | [112](/filings/0001328581-25-000088.md) | [91.0](/filings/0001328581-25-000088.md) | [68.9 d](/filings/0001328581-26-000006.md) | [40.3](/filings/0001328581-26-000027.md) | [62.0](/filings/0001328581-26-000027.md) | [21.8](/filings/0001328581-25-000088.md) | [8.7 d](/filings/0001328581-26-000006.md) | [17.8](/filings/0001328581-26-000027.md) | [57.3](/filings/0001328581-26-000027.md) |
| Diluted EPS | $ per share | [3.58](/filings/0001328581-24-000090.md) | not reported | [2.61](/filings/0001328581-25-000058.md) | [2.84](/filings/0001328581-25-000073.md) | [2.33](/filings/0001328581-25-000088.md) | not reported | [1.06](/filings/0001328581-26-000016.md) | [1.64](/filings/0001328581-26-000027.md) | [0.58](/filings/0001328581-25-000088.md) | not reported | [0.50](/filings/0001328581-26-000016.md) | [1.63](/filings/0001328581-26-000027.md) |
| Basic EPS | $ per share | [3.61](/filings/0001328581-24-000090.md) | not reported | [2.63](/filings/0001328581-25-000058.md) | [2.85](/filings/0001328581-25-000073.md) | [2.34](/filings/0001328581-25-000088.md) | not reported | [1.06](/filings/0001328581-26-000016.md) | [1.64](/filings/0001328581-26-000027.md) | [0.58](/filings/0001328581-25-000088.md) | not reported | [0.50](/filings/0001328581-26-000016.md) | [1.63](/filings/0001328581-26-000027.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,273](/filings/0001328581-23-000096.md) | [950](/filings/0001328581-25-000010.md) | [890](/filings/0001328581-24-000065.md) | [922](/filings/0001328581-24-000079.md) | [762](/filings/0001328581-24-000090.md) | [713](/filings/0001328581-26-000006.md) | [562](/filings/0001328581-25-000058.md) | [481](/filings/0001328581-25-000073.md) | [512](/filings/0001328581-25-000088.md) | [477](/filings/0001328581-26-000027.md) | [339](/filings/0001328581-26-000016.md) | [305](/filings/0001328581-26-000027.md) |
| Current assets | $m | [2,466](/filings/0001328581-23-000096.md) | [2,057](/filings/0001328581-25-000010.md) | [2,217](/filings/0001328581-24-000065.md) | [2,268](/filings/0001328581-24-000079.md) | [2,012](/filings/0001328581-24-000090.md) | [1,886](/filings/0001328581-26-000006.md) | [1,980](/filings/0001328581-25-000058.md) | [1,911](/filings/0001328581-25-000073.md) | [1,853](/filings/0001328581-25-000088.md) | [1,654](/filings/0001328581-26-000027.md) | [1,734](/filings/0001328581-26-000016.md) | [1,800](/filings/0001328581-26-000027.md) |
| Total assets | $m | [3,642](/filings/0001328581-23-000096.md) | [3,459](/filings/0001328581-25-000010.md) | [3,614](/filings/0001328581-24-000065.md) | [3,672](/filings/0001328581-24-000079.md) | [3,442](/filings/0001328581-24-000090.md) | [3,369](/filings/0001328581-26-000006.md) | [3,482](/filings/0001328581-25-000058.md) | [3,446](/filings/0001328581-25-000073.md) | [3,402](/filings/0001328581-25-000088.md) | [3,242](/filings/0001328581-26-000027.md) | [3,342](/filings/0001328581-26-000016.md) | [3,388](/filings/0001328581-26-000027.md) |
| Current liabilities | $m | [695](/filings/0001328581-23-000096.md) | [594](/filings/0001328581-25-000010.md) | [685](/filings/0001328581-24-000065.md) | [692](/filings/0001328581-24-000079.md) | [643](/filings/0001328581-24-000090.md) | [564](/filings/0001328581-26-000006.md) | [702](/filings/0001328581-25-000058.md) | [645](/filings/0001328581-25-000073.md) | [598](/filings/0001328581-25-000088.md) | [493](/filings/0001328581-26-000027.md) | [627](/filings/0001328581-26-000016.md) | [664](/filings/0001328581-26-000027.md) |
| Long-term debt | $m | [445](/filings/0001328581-23-000096.md) | [445](/filings/0001328581-25-000010.md) | [446](/filings/0001328581-24-000065.md) | [446](/filings/0001328581-24-000079.md) | [446](/filings/0001328581-24-000090.md) | [446](/filings/0001328581-26-000006.md) | [446](/filings/0001328581-25-000058.md) | [445](/filings/0001328581-25-000073.md) | [445](/filings/0001328581-25-000088.md) | [445](/filings/0001328581-26-000027.md) | [448](/filings/0001328581-26-000016.md) | [448](/filings/0001328581-26-000027.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,308](/filings/0001328581-24-000090.md) | [2,196](/filings/0001328581-26-000006.md) | [2,257](/filings/0001328581-25-000088.md) | [2,303](/filings/0001328581-25-000088.md) | [2,123](/filings/0001328581-25-000088.md) | [2,151](/filings/0001328581-26-000027.md) | [2,127](/filings/0001328581-26-000027.md) | [2,152](/filings/0001328581-26-000027.md) | [2,143](/filings/0001328581-25-000088.md) | [2,075](/filings/0001328581-26-000027.md) | [2,016](/filings/0001328581-26-000027.md) | [2,026](/filings/0001328581-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [231 d](/filings/0001328581-24-000090.md) | [166 d](/filings/0001328581-26-000006.md) | [27.5](/filings/0001328581-25-000058.md) | [142 d](/filings/0001328581-25-000073.md) | [175 d](/filings/0001328581-25-000088.md) | [94.6 d](/filings/0001328581-26-000006.md) | [(28.5)](/filings/0001328581-26-000016.md) | [33.2 d](/filings/0001328581-26-000027.md) | [118 d](/filings/0001328581-25-000088.md) | [131 d](/filings/0001328581-26-000006.md) | [(16.0)](/filings/0001328581-26-000016.md) | [42.3 d](/filings/0001328581-26-000027.md) |
| Capital expenditure | $m | [31.0 d](/filings/0001328581-24-000090.md) | [116 d](/filings/0001328581-26-000006.md) | [34.3](/filings/0001328581-25-000058.md) | [39.8 d](/filings/0001328581-25-000073.md) | [61.7 d](/filings/0001328581-25-000088.md) | [93.8 d](/filings/0001328581-26-000006.md) | [53.2](/filings/0001328581-26-000016.md) | [79.1 d](/filings/0001328581-26-000027.md) | [55.2 d](/filings/0001328581-25-000088.md) | [54.0 d](/filings/0001328581-26-000006.md) | [39.8](/filings/0001328581-26-000016.md) | [23.5 d](/filings/0001328581-26-000027.md) |
| Dividends paid | $m | [7.9](/filings/0001328581-26-000006.md) | [206](/filings/0001328581-26-000006.md) | [11.2](/filings/0001328581-26-000006.md) | [7.9](/filings/0001328581-26-000006.md) | [201](/filings/0001328581-26-000006.md) | [8.3](/filings/0001328581-26-000006.md) | [10.5](/filings/0001328581-26-000016.md) | [7.9](/filings/0001328581-26-000006.md) | [8.2](/filings/0001328581-26-000006.md) | [8.0](/filings/0001328581-26-000006.md) | [10.4](/filings/0001328581-26-000016.md) | [7.7 d](/filings/0001328581-26-000027.md) |
| Share repurchases | $m | [0.0 d](/filings/0001328581-24-000090.md) | [4.9 d](/filings/0001328581-26-000006.md) | [27.0](/filings/0001328581-25-000058.md) | [61.9 d](/filings/0001328581-25-000073.md) | [69.7 d](/filings/0001328581-25-000088.md) | [36.4 d](/filings/0001328581-26-000006.md) | [53.9](/filings/0001328581-26-000016.md) | [33.9 d](/filings/0001328581-26-000027.md) | [25.0 d](/filings/0001328581-25-000088.md) | [70.4 d](/filings/0001328581-26-000006.md) | [65.5](/filings/0001328581-26-000016.md) | [44.5 d](/filings/0001328581-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.8](/filings/0001328581-23-000096.md) | [39.8](/filings/0001328581-24-000065.md) | [39.8](/filings/0001328581-24-000079.md) | [40.0](/filings/0001328581-24-000090.md) | [40.0](/filings/0001328581-25-000058.md) | [39.6](/filings/0001328581-25-000073.md) | [39.1](/filings/0001328581-25-000088.md) | [38.2](/filings/0001328581-26-000016.md) | [37.8](/filings/0001328581-26-000027.md) | [37.5](/filings/0001328581-25-000088.md) | [36.0](/filings/0001328581-26-000016.md) | [35.2](/filings/0001328581-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,891,351 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001328581-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.